<DOC>
	<DOCNO>NCT02234882</DOCNO>
	<brief_summary>The purpose study assess effect coadministration multiple dose BMS-663068 systemic exposure rosuvastatin .</brief_summary>
	<brief_title>Study Pharmacokinetics</brief_title>
	<detailed_description />
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1 . Signed Informed Consent Form Signed write informed consent must obtain subject accordance requirement study center 's IRB IEC initiation protocolrequired procedure . 2 . Target Population Healthy subject determine clinically significant deviation normal medical history , physical examination finding , vital sign measurement , 12lead ECG measurement , clinical laboratory test result . 3 . Age Reproductive Status Men woman nonchildbearing potential , age 18 50 year , inclusive . Women must document proof childbearing potential . Women must breastfeed . Males sexually active woman childbearing potential ( WOCBP ) must agree follow instruction method ( ) contraception duration treatment study drug ( ) . Women childbearing potential breastfeeding Any significant acute chronic medical illness History rhabdomyolysis biliary disorder , include Gilbert 's disease DubinJohnson disease Smokers ( currently smoke , well stop smoke less 6 month prior start study drug administration ) Alcohol intake exceed 2 standard drink per day ; however , alcohol allow 1 week prior start study drug administration duration study Any sound medical , psychiatric , and/or social reason determine investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>